  No immunogen has been found that elicits a broadly neutralizing antibody ( bNAb) response sufficient for development into an HIV<pathogen> vaccine. In this issue of Cell Host and Microbe , Zhang et al. ( 2018) rationally design an HIV<pathogen> envelope glycoprotein variant that provides new hope that such an immunogen may be attainable.